Chief financial officer
Barry has more than 25 years’ experience as an executive director in rapidly growing life sciences businesses including CFO at Domainex Ltd, COO at Kinapse Ltd and Finance Director at AIM-listed Fulcrum Pharma plc. Before joining Fulcrum Pharma, he was a Finance and Administration Director in biotechnology and medical device companies. Barry is currently also CFO at Edinburgh Molecular Imaging Ltd.
Previously he held senior financial roles in the group head office of Cope Allman International PLC, and trained as a Chartered Accountant with Josolyne Layton-Bennett & Co, now a part of Ernst & Young, Barry has a BSc in Physics from the University of Bristol.